Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Thyroid Neoplasms 1Hypothyroidism 1Goiter 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Triiodothyronine × Clear all
NCT04782856 2024-06-14

Energy Metabolism in Thyroidectomized Patients

Virginia Commonwealth University

Phase 2 Completed
13 enrolled 10 charts
Head & Neck

Goiter, Hypothyroidism, Thyroid Neoplasms

NCT03787303 2022-05-13

B-TREUH

Aultman Health Foundation

Phase 2 Terminated
7 enrolled 14 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡